Today’s Solutions: March 28, 2024

The problem with the standard treatment for asthma is that it’s not beneficial for all patients. In fact, research suggests that one in seven kids has a small difference in their DNA that can cause their symptoms to get worse if given the standard treatment. Fortunately, new research may have an answer to this problem in the form of a simple, cheap genetic test.

Prescribing an asthma treatment: The standard asthma treatment for children is a combination of a steroid inhaler and a medication called salmeterol that opens up the airways. This drug targets a molecule called the beta-2 receptor, and in some people, the gene that produces this molecule is slightly altered — for them, salmeterol can do more harm than good.

In a study at Royal Alexandra Children’s Hospital, researchers set out to see whether testing children for that altered gene prior to prescribing an asthma treatment could improve their quality of life. 241 patients were divided into two groups. One group got the standard treatment, while the other group underwent a genetic test to see if one or both of their copies of the beta-2 receptor gene were altered. This test used samples collected via a simple cheek swab and cost less than $25 per patient. If a patient had at least one altered copy of the gene, they received an alternative to salmeterol (montelukast).

The next step in the study was seeing whether prescribing an asthma treatment based on a young patient’s genetics made a difference in their quality of life. For a year, the researchers checked in with the children to ask them about the severity of their symptoms, how their asthma affected their daily activities, and how it affected their feelings. Each patient received a score between one and seven to rate their quality of life. The researchers then compared the average scores of the patients in the group that underwent genetic testing prior to being assigned an asthma treatment with those that didn’t.

For patients with just one copy of the altered gene, the genetic testing didn’t make much of a difference — their average quality of life score was less than .2 points higher than those in the standard care group. The impact was slightly more pronounced among patients with two altered copies of the gene — their score was more than .4 points higher, which the researchers say translates to a notable improvement in the quality of life.

The results are notable because they show for the first time that “it could be beneficial to test for certain genetic differences in children with asthma and select medication according to those differences.”

Moving forward, the researchers plan to conduct larger trials with children who have less control over their asthma.

Solutions News Source Print this article
More of Today's Solutions

Rowing against the current: Botswana’s women safari guides inspire and empower

In the calm of Botswana's Okavango Delta, where the morning sun creates a golden glow on the water's surface, an amazing metamorphosis is occurring. ...

Read More

The future of healing: 3D printing skin directly onto open wounds

Pennsylvania State University researchers achieved a major medical science breakthrough by being the first team ever to 3D print real human skin tissue directly ...

Read More

These solar-powered barges can scoop up 50 tons of plastic from rivers each day

While removing the plastic waste that currently contaminates the ocean today will be crucial for protecting marine ecosystems, it is arguably more important that ...

Read More

A bold step towards climate action and job creation: The American Climate Corps

The White House announced the creation of the American Climate Corps, a breakthrough program that will transform the climate action landscape. This ambitious project ...

Read More